Peptides News and Research

RSS

Oxytocin affects the heart's response to social isolation

A team of researchers investigating the effects of oxytocin, a peptide produced by the brain that regulates social behavior, has found that it can prevent detrimental cardiac responses in adult female animals exposed to social isolation.

30 Apr 2007

Baxter Healthcare presents phase I inhaled insulin study results

Baxter Healthcare Corporation announced results of a Phase I study that evaluated pulmonary insulin produced with Baxter's PROMAXX microsphere technology and administered using a small, standard dry powder inhaler.

24 Apr 2007

University of Delaware scientist wins NSF career award for tissue engineering

Xinqiao Jia will never forget a visitor to her professor's lab at Fudan University in Shanghai, China, when she was working on her master's degree in polymer chemistry and physics.

21 Apr 2007

Natural ingredient in human blood found to block HIV-1

A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying.

20 Apr 2007

Vaccines to prevent or slow the growth of cancerous tumors

Mayo Clinic researchers have designed a new strategy in the promising field of cancer vaccine research that's proven to be successful in boosting T cells - the immune builders akin to a super defense force against cancer cells.

19 Apr 2007

Natural blood ingredient prevents HIV

Scientists in Germany scientists say they have discovered a natural ingredient in human blood that prevents the HIV-1 virus from infecting immune cells.

19 Apr 2007

Researchers use bacterium to obtain biopreservatives from food

The research group "Estudio de sustancias antagonistas producidas por microorganismos" (Antagonistic substances produced by microorganisms), part of the Microbiology Department of the University of Granada, has succeeded in isolating enterocin AS-48, which could have a medium-term use as food biopreservative.

18 Apr 2007

New vaccine strategy for head and neck cancers

Most attempts to create therapeutic cancer vaccines are based on custom-made approaches that use a patient's own tumor cells to generate a strong immune response against cancer.

18 Apr 2007

More effective therapies for individual cancers - personalized medicine

Genetic and epigenetic variations ensure that no two people are exactly alike, and the same holds true for any two cancers.

18 Apr 2007

Taking a jab at cancer by stimulating the immune system

As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress.

18 Apr 2007

High levels of antibodies - low levels of cancer!

Active immunisation can stimulate the body to produce highly efficient IgE antibodies that attack tumours.

17 Apr 2007

New tumor antigen found with new cloning technique

In recent years, researchers have worked to develop a number of vaccines to help the immune system fight tumors.

16 Apr 2007

GlaxoSmithKline initiates study of PROMACTA in chronic idiopathic thrombocytopenic purpura

GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).

15 Apr 2007

How auxin regulates TIR1 in plants provides clues to new treatments for human diseases

For the first time, scientists from the University of Washington School of Medicine, Indiana University Bloomington and the University of Cambridge have determined how a plant hormone -- auxin -- interacts with its hormone receptor, called TIR1.

5 Apr 2007

Biobased alternative for critical component of many polymer products

Virginia Tech chemists are looking for biobased alternatives and environmentally friendly reaction pathways to replace a toxic intermediate that is a critical component of many polymer products.

3 Apr 2007

Synthetic molecule helps detect heart attack in the making

A new bright spot in heart disease research may soon allow physicians to peer directly into patients' blood vessels and find dangerous cholesterol-filled plaques before they rupture and cause a heart attack.

2 Apr 2007

Scientists create small molecules to probe proteins deep inside cell membrane

Proteins, which form much of the molecular machinery required for life, are the targets of most drug molecules.

2 Apr 2007

New cardiovascular treatment approaches

In an era of increasing death and illness from heart and blood vessel disease - which also can impair kidney function - Mayo Clinic researchers have designed two promising new cardiovascular treatment approaches.

30 Mar 2007

Blood pressure control with Clevidipine

Researchers report that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology's 56th Annual Scientific Session.

30 Mar 2007

Newly discovered peptide could help transplant for diabetes

A peptide developed by scientists at Weill Cornell Medical College may expand the availability and durability of islet cell transplant for patients with type-1 diabetes, which is characterized by a lack of these insulin-producing cells.

21 Mar 2007